Navigation Links
Prostate Cancer Discovered in 40 Percent of Men Who Test Negative for the Disease
Date:12/15/2008

WESTMONT, Ill., Dec. 15 /PRNewswire/ -- Forty percent of men with prostate cancer may not even know they have it, according to a new research study by the Prostate Cancer Foundation of Chicago. The study revealed the standard office biopsy procedure often isn't enough to properly detect prostate cancer. This new research will be published in an upcoming issue of Urology, a national medical journal.

Researchers used an advanced biopsy technique called stereotactic transperineal prostate biopsy (STPB). This was performed on patients with persistent elevated prostate specific antigen (PSA) levels who previously had at least one negative office biopsy. All patients had received transrectal prostate biopsies (TRPB), administered by a urologist.

"Men who have negative transrectal biopsies and continue to have elevated PSA levels should consider STPB because 40% will harbor malignancy," says Michelle Braccioforte, director of research and education for the Prostate Cancer Foundation of Chicago. "Our level of confidence is greatly enhanced with regards to the presence or absence of cancer, and more specifically, the exact location of the cancer within the prostate."

STPB is performed by taking a median of 40 samples of the prostate through the perineum while the patient is under general anesthesia. Performed as an outpatient procedure, it allows more comprehensive sampling, compared to the transrectal method, which takes fewer samples through the rectum. In addition, by taking more samples during STPB, the exact location of the cancer can be pinpointed.

Between April 2004 and January 2008, 747 patients with high PSA levels were studied. All patients had been tested using TRPB at least once and all results had been negative. All patients received the STPB. Biopsy results identified the presence of cancer in 291 (39%) of the patients.

One in six men in the U.S. will be diagnosed with prostate cancer, the most common form of cancer among men. For those with elevated or rising PSA levels, this is a sign that further testing should be administered to rule out prostate cancer.

The Prostate Cancer Foundation of Chicago, located in Westmont, IL, is a not-for-profit organization that conducts ongoing research intended to improve the diagnosis and treatment of prostate cancer. For more information, visit http://www.chicagoprostatefoundation.org to download or call Michelle at 630.654.2515.


'/>"/>
SOURCE The Prostate Cancer Foundation of Chicago
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. USAs largest ever prostate cancer screening program shows high compliance and consistent results
2. Treadmill Desks More Effective in Decreasing Prostate Cancer Risks Than Vitamin and Antioxidant Supplements
3. Hormone therapy for prostate cancer does not appear to increase cardiac deaths
4. Selenium, Vitamins E and C Wont Prevent Prostate Cancer
5. Study finds selenium, vitamin E do not prevent prostate cancer
6. Single Men Less Likely to Get Prostate Screens
7. Treatment Options Are Many for Prostate Cancer
8. ESPN'S Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
9. ESPNs Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
10. Prostate Cancer Stimulates Nerve Growth
11. Prostate cancer drug reduces testosterone levels in as little as 3 days
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... May 06, 2016 , ... Expert ... . , Since launching in September, 2014 Sleepopolis has resided at Sleepopolis-mattress-reviews.com ... now include pillows, sheets, mattress toppers, bed frames, and more. , Founder and ...
(Date:5/6/2016)... Utah (PRWEB) , ... May 06, 2016 , ... ... Step, an online provider of career-focused education and corporate training, and the National ... are pleased to announce Maritza Aquino as the second full-tuition scholarship recipient of ...
(Date:5/6/2016)... Washington, DC (PRWEB) , ... May 06, 2016 ... ... Blum, Executive Vice President at CareFirst Blue Cross BlueShield and Former Principal Deputy ... Officer at CareMore - an Anthem Company; Steve Ondra, MD, Chief Medical Officer ...
(Date:5/5/2016)... ... May 05, 2016 , ... Qrono Inc. , a ... development collaboration with the Australian critical medicine company, Phebra Pty Ltd. , ... LAI medicines can offer improved therapeutic benefits over oral formulations, including better bioavailability, ...
(Date:5/5/2016)... Tampa, FL (PRWEB) , ... May 05, 2016 ... ... hospital in Tampa to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative ... (LAAC) Implant. Since first offering the procedure in April of 2015, Florida Hospital ...
Breaking Medicine News(10 mins):
(Date:5/6/2016)... May 6, 2016 Appoints ... and its Application to Drug Development Including Development of ... , the life sciences consulting firm, today announced that ... an Associate Partner in its Cambridge, MA ... Miller, PhD, in the firm,s Medical Imaging consulting practice ...
(Date:5/5/2016)... 5, 2016 Endo International plc (NASDAQ: ... Douglas S. Ingram , former president of Allergan, Inc. and ... Sisitsky , managing partner of TPG Capital, to its Board ... "Endo recently embarked on a search ... expand the Board,s capabilities. Doug and Todd are experienced leaders, ...
(Date:5/5/2016)... Research and Markets has announced the addition of ...  report to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Emission Tomography (PET) scanner and cyclotron install base in ... the current known number of PET scanners and cyclotrons ... also contains a detailed breakdown of this equipment by ...
Breaking Medicine Technology: